White House Adviser Says Trump Won’t Create ‘FDA for AI’
White House Adviser Says Trump Won’t Create ‘FDA for AI’
Publish Date: 2026-07-05 17:54:00
Source Domain: www.pymnts.com
Here are the key points from the article concerning the White House’s stance on artificial intelligence regulation:
-
No Formal Licensing for AI: Sriram Krishnan, the outgoing artificial intelligence (AI) adviser for the White House, stated that the administration will not require formal licensing for AI technologies.
-
Opposition to Bureaucratic Red Tape: Krishnan emphasized that President Trump has been against creating excessive bureaucratic processes that can hinder technological progress.
-
Laissez-Faire Regulatory Approach: Krishnan is identified as a proponent of a less restrictive approach to AI regulation within the administration.
-
Public Backlash: There is mention of growing public opposition to AI, despite the administration’s deregulation efforts, citing local pushbacks that have halted 75 data center projects in the first three months of the year.
-
Companies Wary of Autonomous AI: The article also highlights that companies are increasingly using AI for research and analysis but remain cautious about allowing AI to perform autonomous actions, as per a PYMNTS Intelligence report.
Ensure to explore the full article for more detailed information and insights.
